<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01930084</url>
  </required_header>
  <id_info>
    <org_study_id>AAAL1354</org_study_id>
    <secondary_id>USAID-OAA-A-12-00027</secondary_id>
    <nct_id>NCT01930084</nct_id>
  </id_info>
  <brief_title>ENGAGE4HEALTH: A Combination Intervention Strategy for Linkage and Retention in Mozambique</brief_title>
  <acronym>E4H</acronym>
  <official_title>ENGAGE4HEALTH: A Combination Strategy for Linkage and Retention in HIV Care Among Adults in Mozambique</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>United States Agency for International Development (USAID)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose: To compare the effectiveness of a combination intervention strategy (CIS),&#xD;
      consisting of point of care (POC) CD4+ testing immediately following HIV diagnosis and&#xD;
      accelerated ART initiation for eligible participants delivered by facility personnel, and&#xD;
      cellular appointment reminders delivered by study personnel, to the standard of care (SOC) on&#xD;
      linkage to and retention in HIV care at 12 months among adults testing positive for HIV in&#xD;
      Mozambique. Additionally, the protocol will assess the incremental effectiveness of CIS+&#xD;
      non-cash financial incentives (FI) compared to CIS without FI on study outcomes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Design: Two-arm cluster site-randomized trial with a pre-post intervention two-sample design&#xD;
      nested in the intervention arm.&#xD;
&#xD;
      Study Population: The study population is any adult who tests HIV positive at the HIV&#xD;
      counseling and testing points participating in this study. The study unit (SU), the level of&#xD;
      randomization for the study, includes specific HIV counseling and testing points at primary&#xD;
      health care clinics and the HIV care and treatment services located in the same health&#xD;
      facility. A total of 10 SU will be included.&#xD;
&#xD;
      Sample Size: A total of 2,250 adults from the 10 study units will be included in the study,&#xD;
      750 in the SOC arm, 750 receiving CIS without FI and 750 receiving CIS+FI.&#xD;
&#xD;
      Participants will be enrolled and followed for 12 months after enrollment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2013</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Linkage to HIV care within 1 month of HIV testing and retention in care 12 months after testing.</measure>
    <time_frame>1 month and 12 months after testing</time_frame>
    <description>An increase in linkage to HIV care within 1 month of HIV testing and retention in care 12 months after testing. Participants are considered to achieve this outcome if they successfully link to the SU HIV care services within 1 month of testing HIV positive as measured from the electronic patient-level database used at the HIV care clinic (EPTS).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to linkage to care</measure>
    <time_frame>12 months</time_frame>
    <description>A decrease in the median time to linkage to care</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Time from ART eligibility to ART initiation</measure>
    <time_frame>12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Proportion of participants with new WHO Stage III/IV event or hospitalization</measure>
    <time_frame>12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Mortality rate 12 months after HIV diagnosis</measure>
    <time_frame>12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Costs and incremental cost-effectiveness ratio of CIS and of CIS+FI</measure>
    <time_frame>12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Proportion of patients receiving POC CD4+ test, short message service (SMS) reminders, accelerated ART initiation (among those eligible based on POC CD4+ test result), and FI</measure>
    <time_frame>12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Proportion of patients reporting that interventions were highly acceptable</measure>
    <time_frame>12 months</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">2004</enrollment>
  <condition>HIV</condition>
  <arm_group>
    <arm_group_label>Combination intervention + incentives</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Point of care CD4+ after HIV diagnosis&#xD;
Accelerated ART initiation&#xD;
SMS appointment reminders&#xD;
Non-cash financial incentives (FI)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combination intervention strategy(CIS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Point of care (POC) CD4+ after HIV diagnosis&#xD;
Accelerated ART initiation&#xD;
SMS appointment reminders</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of care (SOC)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care, no intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Point of care CD4+ after HIV diagnosis</intervention_name>
    <description>Point of care (POC) CD4+ testing immediately following HIV diagnosis</description>
    <arm_group_label>Combination intervention + incentives</arm_group_label>
    <arm_group_label>Combination intervention strategy(CIS)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Accelerated ART initiation</intervention_name>
    <description>Accelerated ART initiation for eligible participants delivered by facility personnel</description>
    <arm_group_label>Combination intervention + incentives</arm_group_label>
    <arm_group_label>Combination intervention strategy(CIS)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SMS appointment reminders</intervention_name>
    <description>Cellular appointment reminders delivered by study personnel</description>
    <arm_group_label>Combination intervention + incentives</arm_group_label>
    <arm_group_label>Combination intervention strategy(CIS)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-cash Financial Incentives</intervention_name>
    <description>Non-cash Financial Incentives</description>
    <arm_group_label>Combination intervention + incentives</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  Testing HIV positive at the largest-volume HIV point of testing (other than prevention&#xD;
             of mother-to-child transmission or tuberculosis) at SU with written proof of test&#xD;
             result&#xD;
&#xD;
          -  Agreeing to be referred to the HIV care services associated with the SU&#xD;
&#xD;
          -  Agreeing to provide locator information&#xD;
&#xD;
          -  Agreeing to adhere to study procedures, including a baseline interview, interviews 1&#xD;
             and 12 months after study enrollment, and extraction of data from the HIV care and&#xD;
             treatment electronic database&#xD;
&#xD;
          -  Able to provide informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Being pregnant at study enrollment&#xD;
&#xD;
          -  Planning on leaving the community where they currently reside in the next 12 months&#xD;
&#xD;
          -  Enrolled in HIV care in the past 6 months at any clinic&#xD;
&#xD;
          -  Initiated ART (for any duration) in the past 6 months at any clinic&#xD;
&#xD;
          -  Currently on ART&#xD;
&#xD;
          -  Does not speak or understand Portuguese or Xitswa/Matswa&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Batya Elul, PhD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chicuque Health Center</name>
      <address>
        <city>Inhambane</city>
        <country>Mozambique</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massinga Health Center</name>
      <address>
        <city>Inhambane</city>
        <country>Mozambique</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maxixe Health Center</name>
      <address>
        <city>Inhambane</city>
        <country>Mozambique</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Morrumbene Health Center</name>
      <address>
        <city>Inhambane</city>
        <country>Mozambique</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Urbano Health Center</name>
      <address>
        <city>Inhambane</city>
        <country>Mozambique</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zavala Health Center and Inharrime Health Center</name>
      <address>
        <city>Inhambane</city>
        <country>Mozambique</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bagamoio Health Center</name>
      <address>
        <city>Maputo</city>
        <country>Mozambique</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jose Macamo Health Center</name>
      <address>
        <city>Maputo</city>
        <country>Mozambique</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mavalane General Hospital</name>
      <address>
        <city>Maputo</city>
        <country>Mozambique</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zimpeto Health Center</name>
      <address>
        <city>Maputo</city>
        <country>Mozambique</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mozambique</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <study_first_submitted>August 23, 2013</study_first_submitted>
  <study_first_submitted_qc>August 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 28, 2013</study_first_posted>
  <last_update_submitted>February 6, 2017</last_update_submitted>
  <last_update_submitted_qc>February 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Batya Elul</investigator_full_name>
    <investigator_title>Assistant Professor of Epidemiology</investigator_title>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>linkage</keyword>
  <keyword>retention</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

